<DOC>
	<DOCNO>NCT01886638</DOCNO>
	<brief_summary>HIV positive patient two fold increase risk develop cardiovascular disease ( heart attack stroke ) . Cardiovascular disease appear due part HIV side effect anti-HIV medication . Abacavir ( important component current HIV treatment regimen ) one medication show associated increase risk heart attack study . The mechanism abacavir unknown . We hypothesise abacavir lead heart disease interact platelet , form blood clot within artery supply heart , subsequent blockage artery cause heart attack . This study aim determine abacavir increase activity ( `` stickiness '' ) platelet , thus provide evidence may promote heart attack . It consist 23 HIV positive men currently well control HIV . Participants take abacavir 15 day addition usual anti-HIV medication . A blood sample assess platelet activity take baseline , follow 15 day therapy ( i.e . time maximal abacavir effect ) 28 day washout period ( determine effect reversible ) .</brief_summary>
	<brief_title>Determining Effect Abacavir Platelet Activation</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Abacavir</mesh_term>
	<mesh_term>Dideoxynucleosides</mesh_term>
	<criteria>&gt; 18 year age Male HIV positive Stable nonabacavir contain antiretroviral regimen Undetectable HIV Viral load HLAB*57*01 allele positivity Previous allergy abacavir Known cardiovascular disease High Baseline cardiovascular risk ( Framingham risk score &gt; 20 % ) Current recent antiplatelet therapy Preexisting platelet bleed disorder ( i.e . Thrombophilia , Thrombocytopenia , Von willebrands disease , Haemophilia ) Significant Chronic liver disease Current Methadone use</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Platelets</keyword>
	<keyword>HIV</keyword>
	<keyword>Cardiovascular disease</keyword>
	<keyword>Acute myocardial infarction</keyword>
	<keyword>Abacavir</keyword>
	<keyword>Antiretrovirals</keyword>
</DOC>